Physician profile
Hamid Hashemi
NPI 1750306585
$2,579.96
in general payments reported to CMS, 2019-2025
11 companies · $563 in 2025
The $563 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $992 · 2020: $357 · 2021: $138 · 2022: $18.11 · 2023: $66.60 · 2024: $445 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $717.01 | 2019-2025 | Total30, Precision7, Rocklatan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $481.94 | 2019-2021 | |
| Biotissue Holdings INC. | $282.60 | 2023-2025 | |
| Coopervision INC. | $224.49 | 2019-2024 | Paragon Crt |
| Sun Pharmaceutical Industries INC. | $215.54 | 2020-2025 | |
| Dompe US, INC. | $192.15 | 2024-2025 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $166.26 | 2019-2023 | Axert |
| Maculogix, INC. | $125.65 | 2019 | |
| Genzyme Corporation | $121.35 | 2019 | |
| Sight Sciences, INC. | $33.57 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamid Hashemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.